Levothyroxine sodium pentahydrate is a pharmaceutical raw material consisting of the sodium salt of the thyroid hormone thyroxine (T4) in a hydrate form. It is primarily supplied to pharmaceutical manufacturers for use in the production of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Levothyroxine sodium pentahydrate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Sodium levothyroxine hydrate
pharmaceutical raw material
Levothyroxine sodium
pharmaceutical raw material
Liothyronine sodium
pharmaceutical raw material
Scopolamine aminoxide hydrobromide
pharmaceutical raw material
Lidocaine hydrochloride monohydrate
pharmaceutical raw material
Paraxanthine
pharmaceutical raw material
DL-Mandelic acid
pharmaceutical raw material
L-thyroxine zwitterion
pharmaceutical raw material
The international HS code for Levothyroxine sodium pentahydrate (CAS 6106-07-6) is 2937.90.
2937.90
2937 90 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
sodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate;pentahydrate
JMHCCAYJTTWMCX-QWPJCUCISA-M
C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)[O-])N.O.O.O.O.O.[Na+]
Sourcing Levothyroxine sodium pentahydrate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.